Danaher Corporation's Fiscal Year is From January To December.
The item "Enterprise-Value-To-Ebitda-Ratio" stands at 21.11 as of 09/30/2025, the lowest value since 12/31/2023.
As of the end of Danaher Corporation's third quarter, the item "Enterprise Value To Ebitda Ratio" stands at 21.11. This represents a decrease of -7.30 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -27.40 percent compared to the value the year prior.
The 1 year change in percent is -27.40.
The 3 year change in percent is 29.28.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Enterprise Value To Ebitda Ratio | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Enterprise Value To Ebitda Ratio | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Enterprise Value To Ebitda Ratio | 172,241,486,586.05 |
![]() | Boston Scientific Corp - Enterprise Value To Ebitda Ratio | 144,567,730,176.00 |
![]() | Stryker Corporation - Enterprise Value To Ebitda Ratio | 139,209,850,880.00 |